In the 1980s, Dr. Kaufman's experience with gene transfer and engineering led him to become a founding scientist at Genetics Institute Inc., where he engineered mammalian cells for high - level
expression of therapeutic proteins, such as
clotting factors that are now used to treat individuals with hemophilia.